Matthew B. Harms, MD

Articles by Matthew B. Harms, MD

Matthew B. Harms, MD, on the Necessity of Tracking Gene Mutations in ALS

March 31st 2023

The associate professor of neurology at Columbia University spoke about the importance of identifying patients with ALS-associated gene mutations as early as possible.

Matthew B. Harms, MD, on Gene Therapy’s Potential to Address Unmet Needs in ALS

ByMatthew B. Harms, MD

March 29th 2023

The associate professor of neurology at Columbia University spoke about the current and future treatment landscape in ALS.

Matthew B. Harms, MD, on Gene Therapy in ALS, MDA 2023

ByMatthew B. Harms, MD

March 6th 2023

The associate professor of neurology at Columbia University spoke about the session he will be chairing at MDA’s 2023 conference.

Matthew B. Harms, MD

Articles by Matthew B. Harms, MD

Matthew B. Harms, MD, on the Necessity of Tracking Gene Mutations in ALS

Matthew B. Harms, MD, on Gene Therapy’s Potential to Address Unmet Needs in ALS

Matthew B. Harms, MD, on Gene Therapy in ALS, MDA 2023

Latest Updated Articles

Trending on CGTlive®

Myrtelle’s Canavan Disease Gene Therapy Effects Significant Decrease in CSF NAA and Increases in Brain Myelin Volume

Regeneron’s Gene Therapy DB-OTO Improves Speech Perception in Children With Otoferlin-Related Hearing Loss